Vitamin B12 Deficiency vs Folate Deficiency: How to Tell Them Apart
Both vitamin B12 and folate deficiency impair DNA synthesis, producing an identical megaloblastic macrocytic anemia with oval macrocytes and hypersegmented neutrophils. The core axis that separates them is neurologic involvement: B12 is a cofactor for methylmalonyl-CoA mutase (needed for myelin synthesis), so only B12 deficiency causes neurologic damage. Methylmalonic acid is the laboratory pivot that arbitrates between them.
How to tell them apart
| Feature | Vitamin B12 (Cobalamin) Deficiency | Folate Deficiency |
|---|---|---|
| Neurologic symptoms | Present and characteristic: subacute combined degeneration (posterior column loss of vibration/proprioception, corticospinal spasticity/weakness), peripheral neuropathy, ataxia, cognitive changes/dementia | Absent — no neurologic symptoms (key distinction) |
| Methylmalonic acid (MMA) | Elevated (methylmalonyl-CoA mutase requires B12) | Normal |
| Dietary source | Found only in animal products; classic in vegans | From leafy vegetables and fortified grains |
| Body stores / time to deplete | Stores last 3–5 years, so deficiency develops slowly | Stores last only 3–4 months, so deficiency develops relatively quickly |
| Site of absorption | IF–B12 complex absorbed in the terminal ileum via cubam receptor | Absorbed in the jejunum |
| Most common developed-world cause | Pernicious anemia — autoimmune destruction of parietal cells with anti-IF/anti-parietal cell antibodies | Inadequate dietary intake (poor folate intake) |
| Biochemical role | Cofactor for methionine synthase and methylmalonyl-CoA mutase (the latter for myelin) | Required for thymidine synthesis (DNA) |
| Treatment | IM cyanocobalamin (or high-dose oral); often lifelong supplementation | Oral folic acid; treat the underlying cause |
The reasoning
Anchor on two findings. First, neurologic signs — subacute combined degeneration, sensory loss, ataxia, or cognitive change — strongly point to B12 deficiency, because folate deficiency never produces them. Second, methylmalonic acid arbitrates the biochemistry: it is elevated in B12 deficiency and normal in folate deficiency, while homocysteine rises in both. Because the anemias look identical on smear, always check BOTH B12 and folate before treating any megaloblastic macrocytic anemia. If B12 is deficient, hunt for the cause (dietary/vegan, pernicious anemia, ileal disease) and confirm pernicious anemia with anti-IF and anti-parietal cell antibodies.
Key tests
- Serum methylmalonic acid: elevated in B12 deficiency, normal in folate deficiency — the single best discriminator
- Serum B12 and serum (or RBC) folate levels: B12 low in cobalamin deficiency; folate low in folate deficiency
- Anti-intrinsic factor antibodies (highly specific) and anti-parietal cell antibodies (sensitive): positive point to pernicious anemia as the cause of B12 deficiency
What they share
- Megaloblastic macrocytic anemia (MCV >100 fL) from impaired DNA synthesis
- Oval macrocytes and hypersegmented neutrophils on peripheral smear
- Glossitis
- Elevated homocysteine
- Rapid reticulocytosis after appropriate replacement (within days)
Pitfalls
- Never give folate alone to a B12-deficient patient: folate corrects the anemia but does not address neurologic damage, masking the disease while subacute combined degeneration progresses irreversibly.
- Assuming a normal smear or homocysteine rules out B12 deficiency — homocysteine is elevated in both; only MMA separates them.
- Delaying treatment of B12 deficiency: hematologic abnormalities resolve within weeks, but neurologic deficits may become permanent the longer treatment is delayed.
- Confusing megaloblastic macrocytosis with non-megaloblastic causes: alcohol and liver disease produce round macrocytes with normal B12/folate and no hypersegmented neutrophils.
- Forgetting that B12 deficiency can also cause pancytopenia, not just anemia.
Practice this the way the exam tests it — on branching cases where your decisions shape the patient.